Skip to main content

Microarray-Tumor Reveal® FFPE

CPT

81277

Synonyms
  • aCGH
  • CGH
  • CMA
  • Microarray Oncology
  • Reveal® SNP Array
  • WGA

Test Details

Methodology

SNP Microarray analysis is performed using the Oncoscan® FFPE platform, which uses more than 220,000 SNP probes with a median spacing of 5.0 kb, within the majority of genes.

Result Turnaround Time

12 - 15 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Use

This test will detect chromosomal imbalance that may be present in neoplastic disorders and clonal evolution. It provides detection of copy-neutral loss of heterozygosity of any chromosome, and the percent and location of homozygosity, that may be associated with cancer gene mutations.

Special Instructions

Pertinent medical findings should accompany the test request form. If prior FISH analysis has been performed, include copy of report. Please direct questions to genetic customer service at 800-345-4363.

This assay currently is not available in New York state.

Limitations

This SNP assay does not detect balanced rearrangements, low-level mosaicism (<10%), marker chromosomes that only contain heterochromatin or tetraploidy. Genotypes in some formalin-fixed tissues are unable to be determined, allowing only genomic dosage to be determined.

This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.

Specimen Requirements

Specimen

Formalin fixed paraffin embedded (FFPE) tissue

Volume

One paraffin block or ten 10-micron thick section slides

Minimum Volume

Sufficient sample to obtain enough DNA to run microarray

Container

Paraffin block transport pouch

Collection Instructions

FFPE specimen should be fixed in 10% neutral-buffered formalin or formaldehyde.

Storage Instructions

Room temperature

Causes for Rejection

Improperly embedded preparation; decalcified bone or bone core

References

Nauen D, Haley L, Lin MT, et al. Molecular analysis of pediatric oligodendrogliomas highlights genetic differences with adult counterparts and other pediatric gliomas. Brain Pathol. 2016 Mar;26(2):206-214.26206478

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
512014 Reveal(R) Tumor Paraffin 512006 Specimen Type 31208-2
512014 Reveal(R) Tumor Paraffin 512007 # of Genotyping Targets N/A
512014 Reveal(R) Tumor Paraffin 512008 Array Type N/A
512014 Reveal(R) Tumor Paraffin 512009 Diagnosis 48000-4
512014 Reveal(R) Tumor Paraffin 512010 Interpretation 62365-2
512014 Reveal(R) Tumor Paraffin 512011 Director Review 48672-0
512014 Reveal(R) Tumor Paraffin 512123 PDF 11502-2
Order Code512014
Order Code NameReveal(R) Tumor Paraffin
Order Loinc
Result Code512006
Result Code NameSpecimen Type
UofM
Result LOINC31208-2
Order Code512014
Order Code NameReveal(R) Tumor Paraffin
Order Loinc
Result Code512007
Result Code Name# of Genotyping Targets
UofM
Result LOINCN/A
Order Code512014
Order Code NameReveal(R) Tumor Paraffin
Order Loinc
Result Code512008
Result Code NameArray Type
UofM
Result LOINCN/A
Order Code512014
Order Code NameReveal(R) Tumor Paraffin
Order Loinc
Result Code512009
Result Code NameDiagnosis
UofM
Result LOINC48000-4
Order Code512014
Order Code NameReveal(R) Tumor Paraffin
Order Loinc
Result Code512010
Result Code NameInterpretation
UofM
Result LOINC62365-2
Order Code512014
Order Code NameReveal(R) Tumor Paraffin
Order Loinc
Result Code512011
Result Code NameDirector Review
UofM
Result LOINC48672-0
Order Code512014
Order Code NameReveal(R) Tumor Paraffin
Order Loinc
Result Code512123
Result Code NamePDF
UofM
Result LOINC11502-2